News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


Views of NZ self-medication body at odds with safety

25 March 2014

Views of New Zealand self-medication body at odds with safety concerns of some members

AFT Pharmaceuticals (AFT) has identified a major error with the formulation of over 1300 cold and flu products used around the world.

Many over-the-counter (OTC) cold and flu products combine phenylephrine and paracetamol. AFT’s groundbreaking research has revealed that when paracetamol is combined with phenylephrine, the level of phenylephrine is effectively twice what it should be (20mg rather than the standard 10mg level that regulators allow).

The research was recently published in the prestigious New England Journal of Medicine. The discovery has received international attention, including in New Zealand, Australia, China, and the United States.

However, the reaction from the New Zealand Self-Medication Industry Association (NZSMI) has been disappointing. NZSMI acts as the local advocacy body for a number of multinational pharmaceutical companies with OTC operations in New Zealand.

Tim Roper, Executive Director at NZSMI, has been very quick to downplay the discovery. He reportedly told TVNZ that the New England Journal of Medicine publication lacked detail. He also implicitly criticised the integrity of the research because AFT has developed a drug that meets the permitted levels of phenylephrine. Thus, he is reported as saying that “the research done indicated a problem with competitive products but not with the ones that are about to be launched by the company that's involved”.

“These comments are nonsensical in our view,” says Dr Hartley Atkinson, Managing Director of AFT. “The research that underpins the discovery is of the highest standard. If it were anything less, the world’s premier medical journal would not publish it. Furthermore, these results were not from a ‘one off’ experiment. The same results were shown across, not one, but three separate clinical studies. The findings from all of the studies have been made available to the regulators and the additional studies submitted in a major article for publication in medical journals.”

“In addition, any possible implication from the NZSMI that the results may be comprised in some way because AFT has developed the correct formulation of an OTC product also make no sense,” said Dr Atkinson. “First, the New England Journal of Medicine simply would not publish the results if it considered they were tainted by commercial gain. Second, AFT would be failing consumers in New Zealand and around the world if it did not attempt to provide a product that actually delivers the functional 10mg dose of phenylephrine set by the regulators. Consumer safety must always be a cornerstone in the design of any pharmaceutical product, and we stand firmly in that camp.”

Ironically many of the multinational pharmaceutical companies that NZSMI represents argued against increasing the level of phenylephrine above 10mg in their submissions to the US Food and Drug Administration in 20071. The comprehensive 72 page report concluded that “oral phenylephrine 10mg is safe and effective as a nasal decongestant for over-the-counter use in adults” but that “there are insufficient data in adults to support the assertion that increasing the dose of phenylephrine to 25mg is necessary to produce clinically meaningful improvements in nasal decongestion with a similar safety profile as the currently available 10mg OTC monograph dose”.

Dr Atkinson adds, “Here is a discovery that shows combining phenylephrine with paracetamol effectively doubles the amount of phenylephrine in a person’s system – precisely the outcome these multinational pharmaceutical companies did not want, as stated in their submissions to the US Food and Drug Administration. Yet the response of the industry body in New Zealand is to raise doubts about AFT’s on-point research”.

The discovery raises important questions around the safe interaction of phenylephrine with paracetamol. It also raises further questions about the safe interaction between phenylephrine and other ingredients which have not been studied by AFT. For example, ascorbic acid (Vitamin C), which is used in some paracetamol and phenylephrine-based cold and flu remedies, can be expected to further increase the interaction between phenylephrine with paracetamol because of the way such ingredients are metabolized.

“Given the consumer safety imperative, NZSMI should be supportive of all efforts to broaden the knowledge base around possible interactions between phenylephrine and other substances. However, based on Tim Roper’s public comments, it appears this is not the position of NZSMI. I think the general public will be disappointed in this attitude. They will see the Association as ducking for cover on this important issue,” said Dr Atkinson.

ENDS

© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 

NZ on Air: More Funding For TV Captions To Increase Access

More funding for TV captions to increase access NZ On Air has increased funding to provide more captions and audio description on television programmes for the hearing and sight impaired. More>>

Music: So Laid Back Country China Album Release

On Friday night, So Laid Back Country China held a gig at Meow for the release of their new album With Knees of Honey in Goodbye Canyon. I briefly spoke with Harriet lead vocals, keyboard) and Michael (lead vocals, guitar) before the gig More>>

Art: Wellington Region Celebrates Matariki

Eight Wellington museums and galleries have joined forces to present a major programme of exhibitions and events to celebrate Matariki 2015, the Māori New Year. The Wellington Matariki Festival will host more than 60 free events and activities between Saturday ... More>>

Wellington: TEDxWellingtonWomen Speakers Unveiled

The lineup is announced today for the highly anticipated upcoming event TEDxWellingtonWomen. Speakers include local women and men who have lived extraordinary lives and have ideas worth spreading. More>>

Culture: RNZB Showcases NZ Artists With Two World Premieres

The Royal New Zealand Ballet’s mixed bill Salute - Remembering WW1 which opens on 22 May will showcase the talents of New Zealand artists working at the top of their field. More>>


Books: Witi Ihimaera To Address ‘State Of NZ Literature’at Festival

6 May 2015 MEDIA RELEASE Witi Ihimaera to Address ‘State of NZ Literature’ at Dunedin Writers and Readers Festival The New Zealand Book Council has chosen the 2015 Dunedin Writers and Readers Festival as the stage for its annual address, which ... More>>

Culture: Historic Māori Portraits Travel To The Czech Republic

Image credit: Gottfried Lindauer, Wahanui Reihana Te Huatare, oil on canvas, Auckland Art Gallery Toi o Tāmaki, gift of Mr H E Partridge, 1915 More>>

Art: Something Felt, Something Shared - Enjoy

Gabrielle Amodeo, Ruby Joy Eade, Clare McLean, Kalya Ward Curated by Emma Ng May 7 – 30, 2015 Opening: Wednesday May 6, 5.30pm Strange frequencies are channelled through personal narratives and poetic placeholders in Something felt, something ... More>>

Culture: Pukeahu Park ANZAC Day Commemoration 2015

Pukeahu Park ANZAC Day Commemoration 2015 Images from New Zealand Defence Force Click for big version A bugler plays The Last Post Click for big version A View from the top of the Carillion Click for big version Faces old and young Click for big ... More>>

Television: MediaWorks Announces Dancing With The Stars Hosts

MediaWorks and BBC Worldwide ANZ are delighted to announce host Dominic Bowden alongside co-host Sharyn Casey for the hit series Dancing with the Stars. More>>

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news